Topic: collaboration agreement
CRUK is set to invest $25 million in SV’s new biotech fund and work with its new partner to pick out research to develop externally.
Streamline your system of agreement and have confidence during ongoing validations.
Pfizer has inked a deal with CytoReason to use its cell-centered models of the immune system for drug discovery.
French Big Pharma Sanofi is walking away from a heart drug disease pact with MyoKardia ahead of data readouts coming later this year.
Gene-editing specialist Horizon Discovery has entered into a collaboration with AstraZeneca to set up a genomics discovery platform.
MilliporeSigma and InnoCore will work to offer a delivery platform for sustained-release formulations for “virtually any” injectable biologic.
BioMarin teamed up with a senior center near its California HQ to turn an environmental cleanup site into new R&D space and housing for the elderly.
Celgene launched a $60 million collaboration with Skyhawk Therapeutics to develop small molecules targeting RNA mis-splicing in neurological diseases.
Samsung is taking its first steps beyond the lower risk, lower reward world of biosimilars by teaming up with Takeda to co-develop drugs.
Lilly and Purdue University have teamed up to work on a new research collaboration.